These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1555269)

  • 1. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
    Mueller HS; Cohen LS; Braunwald E; Forman S; Feit F; Ross A; Schweiger M; Cabin H; Davison R; Miller D
    Circulation; 1992 Apr; 85(4):1254-64. PubMed ID: 1555269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
    Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
    J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
    Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
    J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators.
    Aguirre FV; McMahon RP; Mueller H; Kleiman NS; Kern MJ; Desvigne-Nickens P; Hamilton WP; Chaitman BR
    Circulation; 1994 Jul; 90(1):78-86. PubMed ID: 8026055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
    Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Circulation; 1993 Jan; 87(1):53-8. PubMed ID: 8419024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction.
    Madsen JK; Grande P; Saunamäki K; Thayssen P; Kassis E; Eriksen U; Rasmussen K; Haunsø S; Nielsen TT; Haghfelt T; Fritz-Hansen P; Hjelms E; Paulsen PK; Alstrup P; Arendrup H; Niebuhr-Jørgensen U; Andersen LI
    Circulation; 1997 Aug; 96(3):748-55. PubMed ID: 9264478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
    Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
    Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.
    Terrin ML; Williams DO; Kleiman NS; Willerson J; Mueller HS; Desvigne-Nickens P; Forman SA; Knatterud GL; Braunwald E
    J Am Coll Cardiol; 1993 Dec; 22(7):1763-72. PubMed ID: 8245326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sex differences in incidence of mortality after acute myocardial infarction].
    Trappolini M; Chillotti FM; Rinaldi R; Trappolini F; Coclite D; Napoletano AM; Matteoli S
    Ital Heart J Suppl; 2002 Jul; 3(7):759-66. PubMed ID: 12187637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).
    Gottlieb S; Boyko V; Zahger D; Balkin J; Hod H; Pelled B; Stern S; Behar S
    J Am Coll Cardiol; 1996 Nov; 28(6):1506-13. PubMed ID: 8917265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
    Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
    Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis.
    Purcell IF; Newall N; Farrer M
    QJM; 1999 Jun; 92(6):327-33. PubMed ID: 10616708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
    Barbash GI; Birnbaum Y; Bogaerts K; Hudson M; Lesaffre E; Fu Y; Goodman S; Houbracken K; Munsters K; Granger CB; Pieper K; Califf RM; Topol EJ; Van De Werf F
    Circulation; 2001 Feb; 103(7):954-60. PubMed ID: 11181469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
    Berger PB; Holmes DR; Stebbins AL; Bates ER; Califf RM; Topol EJ
    Circulation; 1997 Jul; 96(1):122-7. PubMed ID: 9236426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial).
    Zahger D; Cercek B; Cannon CP; Jordan M; Davis V; Braunwald E; Shah PK
    Am J Cardiol; 1995 Feb; 75(4):232-6. PubMed ID: 7832129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.